Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update
November 12, 2020 16:01 ET
|
Bionano Genomics
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians...
Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano’s Saphyr to Replace Karyotyping as First-Line Test for Detection and Identification of Structural and Copy Number Variants in Leukemia Patients
November 11, 2020 18:10 ET
|
Bionano Genomics
Saphyr detected all clinically relevant structural variants (SVs) and copy number variants (CNVs) in 100 AML samples making it 100% concordant with standard of careSaphyr also detected additional...
Largest Study To-Date Focused on Undiagnosed Genetic Disease Patients Reveals That Bionano’s Optical Genome Mapping Technology Can Diagnose Significantly More Patients Than Standard of Care Methods Alone
November 05, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study led by scientists and clinicians from the Institute for Human Genetics and the...
Prowess of Bionano Genomics’ Saphyr System in Uncovering Novel Genetic Variations That Cause Cancer and Genetic Disease in Full Display at ASHG 2020
October 27, 2020 17:59 ET
|
Bionano Genomics
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that human genetics researchers using the Saphyr system will present their results at the American...
Rockefeller University Scientist Uses Bionano Saphyr to Analyze Genomes of Patients and Animals Susceptible to COVID-19
October 26, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Dr. Erich Jarvis, a Howard Hughes Medical Institute investigator at the Rockefeller University...
Bionano Genomics Releases Major Update to Its Suite of Software Tools That Simplifies Clinical Analysis, Reduces Time to Actionable Results and Makes Adoption by Clinical Labs Easier
October 21, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) announces the most significant update to its suite of software tools for data analysis since the launch of Saphyr in...
Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing Variants
October 15, 2020 16:30 ET
|
Bionano Genomics
SAN DIEGO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that a study led by scientists and clinicians from the Institute for Human Genetics at the UCSF School of...
Bionano Genomics to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 12
October 15, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific...
Bionano's Saphyr Plays Essential Role in Identifying Three Previously Unknown Genetic Mutation Types in Cancer in Study from Weill Cornell
October 08, 2020 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its Saphyr system played a key role in a research study by Marcin Imielinski, M.D., Ph.D.,...
Boston Children’s Hospital Is Using Bionano’s Saphyr To Study Children With Severe COVID-19 Disease
October 05, 2020 16:15 ET
|
Bionano Genomics
SAN DIEGO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that a team led by Drs. Catherine Brownstein, Director of the Molecular Genetics Core Facility, and...